These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 9673)

  • 1. Effect of beta-blocking agents in experimental atherosclerosis of cocks.
    Reinis Z; Lojda Z; Heyrovský A; Horáková D; Reisenauer R
    Rev Czech Med; 1976; 22(3):117-26. PubMed ID: 9673
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115), practolol and propranolol on the lipid content of the rat serum].
    Leonhardt U; Nürnberger H; Femmer K
    Pharmazie; 1975 Oct; 30(10):656-8. PubMed ID: 690
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S; Simons LA; Hickie JB; Chang S
    Artery; 1990; 17(2):60-70. PubMed ID: 1968740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of cordanum and propranolol on coronary resistance].
    Tverskaia MS; Kositskiĭ GI
    Biull Eksp Biol Med; 1988 Jun; 105(6):690-2. PubMed ID: 2898952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On the effect of a beta-receptor blocking agent (propranolol) on the turnover rate of free fatty acids and their incorporation rate into plasma triglycerides in hyperthyreosis].
    Sandhofer F; Sailer S; Bolzano K; Braunsteiner H
    Schweiz Med Wochenschr; 1967 Oct; 97(40):1319-23. PubMed ID: 5589278
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma free fatty acids and cholesterol in propranolol-treated rabbits.
    Sable-Amplis R; Agid R
    Biomedicine; 1977 Mar; 27(2):76-8. PubMed ID: 861355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of a beta-blocking agent on the adipokinetic action of corticotropin in humans].
    Giordano G; Marcenaro A; Pompei A
    Arch Maragliano Patol Clin; 1970; 26(4):239-57. PubMed ID: 4394963
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of nonselective and cardioselective beta-adrenergic blockade on fatty acid metabolism in the myocardium].
    Abidova SS; Ovchinnikov IV; Gimmel'farb GN
    Farmakol Toksikol; 1987; 50(5):29-31. PubMed ID: 2891565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog].
    Berlan M
    C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental atherosclerosis in normal and subdiabetic rabbits. I. Short-term studies.
    Wellmann KF; Volk BW
    Arch Pathol; 1970 Sep; 90(3):206-17. PubMed ID: 4194992
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the beta-adrenergic blocking agent bupranolol on the plasma renin activity in normotensive rats].
    Placheta P; Singer E; Kraupp O
    Arzneimittelforschung; 1977; 27(11):2063-6. PubMed ID: 23790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of adrenergic beta-blocking agents on the serum insulin and glucagon response to oral glucose load in normal and diabetic subjects].
    Ferlito S; Volpicelli D; Del Campo F; Romano F; Modica L
    Clin Ter; 1981 May; 97(4):333-47. PubMed ID: 6113914
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of bucindolol on plasma HDL cholesterol subfractions and other plasma lipids in essential hypertensive patients.
    Lehtonen A; Tanskanen A; Temmerman J
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):448-51. PubMed ID: 2888737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies on the effect of caffeine on the development of atherosclerosis in rabbits.
    Kedra M; Poleszak J; Chibowski D; Cholewa J
    Pol Med J; 1970; 9(5):1045-52. PubMed ID: 5510272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of acoustic stimulation on lipid metabolism, indices of the blood coagulation system and development of experimental atherosclerosis in rabbits].
    Deriagina GP; Sinitsyna TS; Veselova TV
    Fiziol Zh SSSR Im I M Sechenova; 1976 Aug; 62(8):1171-81. PubMed ID: 186333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of the beta-receptor blockers propranolol and talinolol on glucose-orciprenaline induced insulin secretion, glucose tolerance and the behavior of nonesterified free fatty acids in metabolically normal probands].
    Möricke R; Marek H
    Z Gesamte Inn Med; 1981 Mar; 36(5):263-7. PubMed ID: 6113715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of propranolol on the serum lipids in diabetics with coronary heart disease.
    Safwat HM; Sharawy M; El Safouri S
    J Egypt Med Assoc; 1978; 61(9-10):577-83. PubMed ID: 262244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.